Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4870-4875

  Huang, Chiun Sheng ^a   Chern, Herng Der ^b   Chang, King Jen ^a   Cheng, Chun Wen ^b,c   Hsu, Su Ming ^a   Shen, Chen Yang ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL ESTROGEN; CYTOCHROME P450 ISOENZYME; ESTROGEN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; FEMALE; GENOTYPE; HUMAN; HYDROXYLATION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TAIWAN;

BODY MASS INDEX; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CONFIDENCE INTERVALS; CYTOCHROME P-450 CYP1A1; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MENARCHE; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; REFERENCE VALUES; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; TAIWAN;

EID: 0033213920     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hulka, B. S., and Stark, A. T. Breast cancer: cause and prevention. Lancet, 346: 883-887, 1995.
2. Kelsey, J. L., Gammon, M. D., and John, E. M. Reproductive factors and breast cancer. Epidemiol. Rev., 15: 36-47, 1993
3. Trichopoulos, D., MacMahon, B., and Cole, P. The menopause and breast cancer risk. J. Nail. Cancer Inst, 48: 605-613, 1972.
4. Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
5. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L., and Rogan, E. C. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 94: 10937-10942, 1997.
6. Yager, J. D., and Liehr, J. G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36: 203-232, 1996.
7. Zhu, B. T., and Conney, A. H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res., 58: 2269-2277, 1998.
8. Service, R. F. New role for estrogen in cancer? Science (Washington DC), 279: 1631-1633, 1998.
9. Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Bell, D. A., Selmin, O., Watson, M. A., Hoffman, S., Comstock, G. W., and Yager, J. D. An association between the allele coding for a low activity variant of calechol-O-methyltransferase and the risk for breast cancer. Cancer Res., 57: 5493-5497, 1997.
10. Picado-Leonard, J., and Miller, W. L. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA (N. Y.), 6: 439-448, 1987.
11. Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novelli, P., Franks, S., and Williamson, R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet., 3: 1873-1876, 1994.
12. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., and Henderson, B. E. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res., 57: 1063-1065, 1997.
13. Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., and Henderson, B. E. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res., 58: 585-587, 1998.
14. Zhu, B. T., and Conney, A. H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (Lond.), 19: 1-27, 1998.
15. Fishman, J., Osborne, M. P., and Telang, N. T. The role of estrogen in mammary carcinogenesis. Ann. N. Y. Acad. Sci., 768: 91-100, 1995.
16. van Aswegen, C. H., Purdy, R. H., and Wittliff, J. L. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptor human breast cancers. J. Steroid Biochem., 32: 485-492, 1989.
17. MacLusky, N. J., Barnea, E. R., Clark, C. R., and Naftolin, F. Catechol estrogens and estrogen receptors. In: G. R. Merriam and M. B. Lipsett (eds.), Catechol Estrogens, pp. 151-165. New York: Raven Press, 1983.
18. Kabat, G. C., Chang, C. J., Sparano, J. A., Sepkovie, D. W., Hu, X. P., Khalil, A., Rosenblatt, R., and Bradlow, H. L. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomark. Prev., 6: 505-509, 1997.
19. Bradlow, L., Telang, N. T., and Osbom, M. P. Estrogen metabolites as bioreactive modulators of tumor initiators and promoters. Adv. Exp. Med. Biol., 387: 285-296, 1996.
20. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.
21. Fishman, J., and Martucci, C. Biological properties of 16α-hydroxyestrone: implications in estrogen physiology and pathophysiology. J. Clin. Endocrinol. Metab., 51: 611-615, 1980.
22. Taioli, E., Trachman, J., Chen, X., Toniolo, P., and Garte, S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55: 3757-3758, 1995.
23. Garte, S., Zocchetti, C., and Taioli, E. Gene-environment interactions in the application of biomarkers of cancer susceptibility in epidemiology. In: P. Toniolo, P. Boffetta, D. E. G. Shuker, N. Rothman, B. Hulka, and N. Pearce (eds.), Application of Biomarkers in Cancer Epidemiology, pp. 251-264. Lyon, France: IARC, 1997.
24. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A . Ford, T. D., and Shields, P. G. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55: 3483-3485, 1995.
25. Ishibe, N., Hankinson, S. E., Colditz, G. A., Spiegelman, D., Willett, W. C., Speizer, F. E., Kelsey, K. T., and Hunter, D. J. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res., 58: 667-671, 1998.
26. Huang, C. S., Shen, C. Y., Chang, K. J., Hsu, S. M., and Chem, H. D. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br. J. Cancer, 80: 1838-1843, 1999.
27. Petersen, D. D., McKinney, C. E., Ikeya, K., Smith, H. H., Bale, A. E., McBride, O. W., and Nebert, D. W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am. J. Hum. Genet., 48: 720-725, 1991.
28. Landi, M. T., Bertazzi, P. A., Shields, P. G., Clark, G., Lucier, G. W., Garte, S. J., Cosma, G., and Caporaso, N. E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4: 242-246, 1994.
29. Malins, D. C., Holmes, E. H., Polissar, N. L., and Gunselman, S. J. The etiology of breast cancer: characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer (Phila.), 71: 3036-3043, 1993.
30. Mallins, D. C., Polissar, N. L., and Gunselman, S. J. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. USA, 93: 2557-2563, 1996.
31. Friedberg, E. C., Walker, G. C., and Siede, W. DNA Repair and Mutagenesis, pp. 1-58. Washington DC: ASM Press, 1995.
32. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., and Weinshilboum, R. M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatrie disorders. Pharmacogenetics, 6: 243-250, 1996.
33. Thompson, P. A., Shields, P. G., Freudenheim, J. L., Stone, A., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., Kadlubar, F. F., and Ambrosone, C. B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status and breast cancer risk. Cancer Res., 58: 2107-2110, 1998.
34. Millikan, R. C., Pittman, G. S., Tse, C K. J., Duell, E., Newman, B., Savitz, D., Moorman, P. G., Boissy, R. J., and Bell, D. A. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (Lond.), 19: 1943-1947, 1998.
35. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphism of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
36. Bernstein, L., Yuan, J. M., Ross, R. K., Pike, M. C., Hanisch, R., Lobo, R., Stanczyk, F., Gao, Y. T., and Henderson, B. E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control, 1: 51-58, 1990.
37. Yang, P. S., Yang, T. L., Liu, C. L., Wu, C. W., and Shen, C. Y. A case-control study of breast cancer in Taiwan. Br. J. Cancer, 75: 752-756, 1997.
38. Lou, M. A., Tseng, S. L., Chang, S. F., Yue, C. T., Chang, B. L., Chou, C. H., Yang, S. L., The, B. H., Wu, C. W., and Shen, C. Y. Novel patterns of p53 abnormality in breast cancer from Taiwan: experience from a low incidence area. Br. J. Cancer, 75: 746-751, 1997.
39. Lo, Y. L., Yu, J. C., Huang, C. S., Tseng, S. L., Chang, T. M., Chang, K. J., Wu, C. W., and Shen, C. Y. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int. J. Cancer, 79: 580-587, 1998.
40. Tseng, S. L., Yu, J. C., Yue, C. T., Chang, S. F., Chang, T. M., Wu, C. W., and Shen, C. Y. Allelic loss at BRCA1, BRCA2 in relation to TP53 abnormality in breast cancer. Genes Chromosomes Cancer, 20: 377-382, 1997.
41. Huang, C. S., Chern, H. D., Shen, C. Y., Hsu, S. M., and Chang, K. J. Association between N-acetyl-transferase 2 (NAT2) genetic polymorphism and development of breast cancer in postmenopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int. J. Cancer, 82: 175-179, 1999.
42. Kelsey, J. L. Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15: 36-47, 1993.
43. Kleinbaum, D. G., Kupper, L. L., and Morgenstern, H. Epidemiologic Research. New York: Van Nostrand Reinhold, 1982.
44. Russo, J., Tay, L. K., and Russo, I. H. Differentiation of the mammary gland and susceptibility to Carcinogenesis. Breast Cancer Res. Treat., 2: 5-73, 1982.
45. MacMahon, B., Trichopoulos, D., Brown, J., Andersen, A. P., Cole, P., deWaard, F., Kauranierm, T., Polychronopoulou, A., Ravnihar, B., Stormby, N., and Westlund, K. Age at menarche, urine estrogens and breast cancer risk. Int. J. Cancer, 10:427-431, 1982.
46. Dunning, A. M., Healey, C. S., Pharoah, P. D. P., Foster, N. A., Lipscombe, J. M., Redman, K. L., Easton, D. F., Day, N. E., and Ponder, B. A. J. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br. J. Cancer, 77: 2045-2047, 1998.
47. Bailey, L. R., Roodi, N., Verrier, C. S., Yee, C. J., Dupont, W. D., and Pari, F. F. Breast cancer and CYP1A1, CSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res., 58: 65-70, 1998.
48. Bernstein, L., and Ross, R. K Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15: 48-65, 1993.